Medistep Health.

How has been the historical performance of Medistep Health.?

Medistep Health has shown significant growth over the past three years, with net sales increasing from 7.46 Cr in Mar'23 to 49.65 Cr in Mar'25, and profit after tax rising from 0.41 Cr to 4.14 Cr. The company has also improved its equity capital and cash flow management during this period.

Answer:<BR>The historical performance of Medistep Health shows significant growth over the past three years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Medistep Health's net sales increased from 7.46 Cr in Mar'23 to 31.62 Cr in Mar'24, and further to 49.65 Cr in Mar'25, indicating a strong upward trend. Total operating income mirrored this growth, rising from 7.46 Cr in Mar'23 to 49.65 Cr in Mar'25. The total expenditure also rose significantly from 6.87 Cr in Mar'23 to 44.06 Cr in Mar'25, reflecting the company's expansion efforts. Operating profit (PBDIT) improved from 0.59 Cr in Mar'23 to 5.59 Cr in Mar'25, while profit before tax rose from 0.55 Cr to 5.54 Cr in the same period. Profit after tax followed suit, increasing from 0.41 Cr in Mar'23 to 4.14 Cr in Mar'25. The company's equity capital grew from 1.07 Cr in Mar'23 to 10.47 Cr in Mar'25, and total liabilities increased from 14.95 Cr to 22.98 Cr. Cash flow from financing activities showed a net inflow of 1.00 Cr in Mar'25, compared to an outflow of 7.00 Cr in Mar'24, indicating improved cash management. Overall, Medistep Health has demonstrated robust growth in sales and profitability, alongside an increase in equity and total assets.

Is Medistep Health. overvalued or undervalued?

As of November 13, 2025, Medistep Health is considered very attractive with a PE ratio of 9.37 and an EV to EBIT ratio of 6.86, significantly lower than its peers, indicating it is undervalued despite a strong recent weekly return of 21.88%.

As of 13 November 2025, the valuation grade for Medistep Health. has moved from does not qualify to very attractive. This indicates a significant improvement in its valuation outlook. The company is currently assessed as undervalued, supported by a PE ratio of 9.37, an EV to EBIT ratio of 6.86, and a robust ROCE of 34.41%. <BR><BR>In comparison to its peers, Medistep Health. stands out with a much lower PE ratio than Sun Pharma (36.15) and Divi's Lab (70.4), both of which are categorized as expensive. Additionally, its EV to EBITDA ratio of 6.82 is significantly more favorable than the industry averages, reinforcing its attractive valuation. While Medistep Health. has shown a strong weekly return of 21.88% compared to the Sensex's 1.45%, its longer-term performance metrics remain to be seen.

Why is Medistep Healthcare Ltd falling/rising?

As of 03-Apr, the stock price of Medistep Healthcare Ltd is at 17.20, unchanged from the previous session. The stock has seen significant declines over various periods, trading below moving averages and experiencing reduced investor participation, indicating a negative outlook.

As of 03-Apr, the stock price of Medistep Healthcare Ltd is currently at 17.20, with no change from the previous trading session. The stock has experienced a significant decline over various periods, with a 1-week drop of 5.75% and a 1-month decrease of 21.82%. Year-to-date, the stock has fallen by 25.54, which is notably worse than the Sensex's decline of 13.08% in the same timeframe.<BR><BR>Today's performance indicates that while Medistep Healthcare has outperformed its sector by 0.83%, it is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend in the stock's performance. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 53.13% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>Overall, the combination of a significant decline in stock price over various periods, trading below moving averages, and falling investor participation contributes to the negative outlook for Medistep Healthcare Ltd.

Why is Medistep Healthcare Ltd falling/rising?

As of 04-Apr, the stock price of Medistep Healthcare Ltd is at 17.20, unchanged from the previous session, and has seen significant declines over various periods. The stock is trading below all moving averages, indicating a bearish trend, compounded by decreased investor participation and lower trading volumes.

As of 04-Apr, the stock price of Medistep Healthcare Ltd is currently at 17.20, showing no change from the previous trading session. The stock has experienced a significant decline over various periods, with a 1-week drop of 5.75%, a 1-month decrease of 21.82%, and a year-to-date fall of 25.54%. In contrast, the benchmark Sensex has also declined, but to a lesser extent, with a 1-month drop of 8.66% and a year-to-date decrease of 13.08%. <BR><BR>Today's performance indicates that Medistep Healthcare Ltd has outperformed its sector by 0.83%. However, it is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 53.13% compared to the 5-day average. This decline in trading activity may further contribute to the stock's lack of upward momentum. <BR><BR>Overall, the combination of significant declines over multiple time frames, lower trading volumes, and underperformance relative to moving averages indicates that Medistep Healthcare Ltd is currently facing downward pressure on its stock price.

Why is Medistep Healthcare Ltd falling/rising?

As of 05-Apr, Medistep Healthcare Ltd's stock price is at 17.20, unchanged from the previous day, with significant declines over various periods, including a 25.54% drop year-to-date. The stock is underperforming relative to moving averages and has seen reduced investor participation, indicating negative sentiment.

As of 05-Apr, Medistep Healthcare Ltd's stock price is currently at 17.20, with no change from the previous day (0.00%). The stock has experienced a significant decline over various time periods, including a 5.75% drop over the past week and a 21.82% decrease over the past month. Year-to-date, the stock has fallen by 25.54%, which is notably worse than the Sensex's decline of 13.08% during the same period.<BR><BR>Today's performance indicates that while Medistep Healthcare has outperformed its sector by 0.83%, it is still trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend in the stock's performance. Additionally, there has been a significant drop in investor participation, with delivery volume on April 1 falling by 53.13% compared to the 5-day average. This decline in trading activity further indicates a lack of confidence among investors.<BR><BR>Overall, the combination of substantial price declines over various periods, underperformance relative to moving averages, and reduced investor participation contributes to the negative sentiment surrounding Medistep Healthcare Ltd's stock, leading to its current price stagnation.

Which are the latest news on Medistep Health.?